48 related articles for article (PubMed ID: 31060930)
1. Use of Dengvaxia® in Australian travellers: a case series.
Zhu Y; Mills DJ; Mills C; Lau CL; Furuya-Kanamori L
J Travel Med; 2024 Jun; 31(4):. PubMed ID: 38579018
[No Abstract] [Full Text] [Related]
2. Initiatives and Challenges of Dengue Incidence in the Philippines.
Cordero DA
J Infect Dis; 2024 May; 229(5):1597-1598. PubMed ID: 38373263
[No Abstract] [Full Text] [Related]
3. Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.
Shukla R; Ramasamy V; Shanmugam RK; Ahuja R; Khanna N
Front Cell Infect Microbiol; 2020; 10():572681. PubMed ID: 33194810
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous Dengue Virus Inoculation Triggers Strong B Cell Reactions but Contrastingly Poor T Cell Responses.
Marcial-Juárez E; García-Cordero J; Maqueda-Alfaro RA; Saucedo-López RE; Sánchez-Torres LE; Cedillo-Barrón L; Flores-Romo L
Virol Sin; 2020 Oct; 35(5):575-587. PubMed ID: 32314276
[TBL] [Abstract][Full Text] [Related]
5. A review of Dengvaxia®: development to deployment.
Thomas SJ; Yoon IK
Hum Vaccin Immunother; 2019; 15(10):2295-2314. PubMed ID: 31589551
[TBL] [Abstract][Full Text] [Related]
6. Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era?
Galula JU; Salem GM; Chang GJ; Chao DY
Hum Vaccin Immunother; 2019; 15(10):2328-2336. PubMed ID: 31314657
[TBL] [Abstract][Full Text] [Related]
7. Dengvaxia researcher charged.
Chatterjee P
Lancet Infect Dis; 2019 Jun; 19(6):584-585. PubMed ID: 31060930
[No Abstract] [Full Text] [Related]
8. Philippine immunization coverage and dengvaxia: An infodemiological study.
Jamora RDG; Lim MAR; Espiritu AI
Pediatr Int; 2023; 65(1):e15623. PubMed ID: 37767858
[TBL] [Abstract][Full Text] [Related]
9. Implications of information heard about Dengvaxia on Filipinos' perception on vaccination.
Mabale MAA; Tejero LMS; Montes LA; Collante MTM; Tempongko MSB; Tolabing MCC
Vaccine; 2024 Mar; 42(7):1673-1681. PubMed ID: 38350770
[TBL] [Abstract][Full Text] [Related]
10. Dengue vaccines regulatory pathways: a report on two meetings with regulators of developing countries.
Mahoney R; Chocarro L; Southern J; Francis DP; Vose J; Margolis H
PLoS Med; 2011 Feb; 8(2):e1000418. PubMed ID: 21364969
[TBL] [Abstract][Full Text] [Related]
11. The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries.
Aguiar M; Stollenwerk N; Halstead SB
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005179. PubMed ID: 28002420
[TBL] [Abstract][Full Text] [Related]
12. Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness.
Larson HJ; Hartigan-Go K; de Figueiredo A
Hum Vaccin Immunother; 2019; 15(3):625-627. PubMed ID: 30309284
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
